Company Search:
Advanced Search
Sponsored Links
Bavarian Nordic A/S - ADR Company Snapshot
Bavarian Nordic A/S - ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic A/S - ADR with three other companies in this sector in the United States: Foundation Medicine Inc (2016 sales of $116.87 million of which 100% was Diagnostic), Galapagos NV ($167.34 million of which 80% was R&D), and Retrophin Inc ($133.59 million of which 100% was Biotechnology).

Sales Analysis. Bavarian Nordic A/S - ADR reported sales of $149.29 million for the year ending December of 2016. This represents a decrease of 1.1% versus 2015, when the company's sales were $150.90 million.
  Stock Performance Chart for Bavarian Nordic A/S - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 12.56
(Figures in U.S. Dollars)
1 Week 3.8%   13 Weeks 6.9%  
4 Weeks -13.4%   52 Weeks -4.8%  
Bavarian Nordic A/S - ADR Key Data:
  Ticker: BVNRY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 149,289,771
(Year Ending Jan 2017).
Employees: 437
  Currency: U.S. Dollars Market Cap: 1,205,383,389
  Fiscal Yr Ends: December Shares Outstanding: 95,970,015
  Share Type: Common Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.